A Mobile Medicine Insider’s Take on the Amazon/One Medical Deal
Once You Misuse Data One Time, I Never Trust You in a Medical Context
I have no axe to grind. I don’t care. I am not currently and don’t plan to become a One Medical Patient so it doesn’t affect me at all.
The good news: They will learn or earn.
What’s 3.5B that’s barely a sneeze for them, right.
The Deal Basics
Here’s the basic facts of the deal according to Becker’s: https://www.beckershospitalreview.com/disruptors/why-amazon-wants-to-buy-one-medical.html
What Could be Good About it
I think this post represents a good cautiously optimistic take: https://www.linkedin.com/posts/alanayers_medicareadvantage-populationhealth-emr-activity-6955900539180056577-VkwH?utm_source=linkedin_share&utm_medium=ios_app
Once You Misuse Data Once, I Never Trust You in a Medical Context
I’m heavily biased to not trust and dislike data misuse. Beyond when organizations demonstrate data misuse, it’s then hard for me to find merit in said organizations for MEDICINE specifically. If you don’t have a good record on privacy, I don’t trust your company for medicine, even if you have some good privacy and cybersecurity people working there. The ranks of people with my mentality are growing as evidenced by my most viral tweet ever linking the explanation of what that annoying web app slowness is, “surveillance lag.” I am also biased by my own career experience of a history of having worked in a heavily regulated life sciences context (highly regulated is necessary for trust with medical stakeholders) where executives were sometimes hired from outside consumer companies. Let’s just say that legal acumen, compliance, and regulatory alignment suffers in this situation.
If People Understood the State of Technical Privacy, They’d be Horrified
While perhaps most people don’t care about privacy today in a technical context because they don’t understand the technologies involved across devices, connectivity/networking, and apps. It’s in fact normal human nature of adult development to prefer privacy. The deeply technical healthcare IT industry leaders that I respect and trust are incredibly focused on privacy and I predict that privacy’s importance together with cybersecurity will eclipse most other capabilities in the coming years in a technology context. First for medicine, then the rest of the market. Medigram is not interested in selling customer data in any form.
I explained in this post that when looking at how the consumer or patient experiences devices, connectivity, and apps in a consumer and even HIPAA context, there is a complete lack for practical purposes of any real privacy.
The Distance Between the Consumer Tech World and Medicine is Planets, Not Miles
For people in medicine who want to know the “what” on the new federal privacy bill, everything you need to know is here. Where The American Data Privacy Protection Act Stands Today Lacks Significant Relevance to Medicine Right Now: https://sherridouville.medium.com/how-the-american-data-privacy-protection-act-activity-of-today-lacks-relevance-to-medicine-right-75d85992c81c
A few things to ponder:
News of a shareholder suit a few months ago: https://www.linkedin.com/posts/sdouville_shareholder-amazons-astronomical-misuse-activity-6932338823586619392-kHxz?utm_source=linkedin_share&utm_medium=ios_app
From a consumer safety standpoint, there’s a reaction even before this from EFF: https://www.eff.org/deeplinks/2022/07/ring-reveals-they-give-videos-police-without-user-consent-or-warrant
Only time will tell if this transaction and the data involved is handled honestly or ethically.
Who do you trust? What are your priorities? That will determine your views on this event.
Their Prior Fine is Just a Sneeze
One thing you can bank on is that the OIG will be watching them closely: https://www.justice.gov/usao-sdny/pr/us-attorney-announces-settlement-fraud-lawsuit-against-online-pharmacy-overdispensing
What Can Make the Outlook More Positive
If we see Amazon keeping One Medical completely separate with no reporting responsibilities nor interaction with consumer legacy or cloud executives of Amazon; then my outlook turns more positive. This sentiment of keeping consumer oriented and cloud executives away from the medical market due to ethical and scientific misalignments applies broadly in my mind. Regulatory change on privacy will be very painful for the tech sector and the layering of medicine on top of that looks irreconcilable to me.
Medicine is from Mars, tech is from Mercury: https://medium.com/@sherridouville/culture-conflict-tech-medical-latter-immune-from-propaganda-opinions-in-medicine-7edccd474a97
In summary, nowhere is misalignment more pronounced than between consumer and medicine in the tech sector. Great move by J&J to spinout its consumer business from Pharma and Medtech because it completely makes sense; the differences are even more stark in software from privacy and cybersecurity perspectives:
By Sherri Douville, CEO at Medigram, the Mobile Medicine company. Recognized in 8 categories of top CEOs by Board Room Media (Across SMS, mHealth, iOS, IT, Database, Big Data, Android, Healthcare). Top ranked medical market executive worldwide and #1 ranked in mobile technologycategories (mhealth, iOS, Android), #1–2 (on any given day) for the cybersecurity market in the U.S. on Crunchbase. Best selling editor/author, Mobile Medicine: Overcoming People, Culture, and Governance & Advanced Health Technology: Managing Risk While Tackling Barriers to Rapid Acceleration